[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] # CG Oncology, Inc. Common stock (CGON) CG Oncology presents positive Phase X bladder cancer data, driving high sentiment and social engagement, despite a minor analyst downgrade. ### About CG Oncology, Inc. Common stock CG Oncology, Inc. is a biopharmaceutical company focused on developing treatments for bladder cancer. CG Oncology, Inc. Common stock uses the ticker $CGON for trading. Listed in the [Stocks](/list/stocks) category. ### Insights - CG Oncology, Inc. Common stock (CGON) social dominance hit XXXXXX which is XXX% higher than it's daily average. - CG Oncology, Inc. Common stock (CGON) sentiment near a 52-week high at XX. - CG Oncology, Inc. Common stock (CGON) engagements hit 53.5K which is XXX% higher than it's daily average. - CG Oncology, Inc. Common stock (CGON) trading volume is up XXXXX% from the previous week. - CG Oncology, Inc. Common stock (CGON) social dominance is up XXXXXX% from the previous X months. - CG Oncology, Inc. Common stock (CGON) engagements is up XXXXX% from the previous month. ### Price: $XXXXX  [Price 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/close.tsv) The stock price is likely increasing due to positive clinical trial data, high sentiment, and a surge in social engagement, supported by a Guggenheim buy rating and target price of $90, despite a recent minor price drop. 24-Hour: -XXXX% 7-Day: -XXXX% 30-Day: XXXX% 1-Year High: $XXXXX on 2025-11-25 1-Year Low: $XXXXX on 2025-04-08 ### AltRank: XXX  [AltRank 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/alt_rank.tsv) CG Oncology, Inc. Common stock (CGON) is currently AltRank #662 based on combined combined social and market metrics Daily Average: XXXXX X Week: XXX -XX X Month: XXX -XXX X Months: XXX +84 X Year: XXX -XXX 1-Year High: XXXXX on 2025-08-11 1-Year Low: XX on 2025-04-28 ### Galaxy Score: XXXXX  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/galaxy_score.tsv) Current Value: XXXXX Daily Average: XX X Week: XX -XX X Month: XX -X X Months: XX -X X Year: XX -XX 1-Year High: XX on 2025-03-04 1-Year Low: X on 2025-07-31 ### Engagements: XXXXXX (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/interactions.tsv) Current Value: XXXXXX Daily Average: XXXXX X Week: XXXXXX +144% X Month: XXXXXXX +215% X Months: XXXXXXXXX +51% X Year: XXXXXXXXX +39% 1-Year High: XXXXXXX on 2025-04-28 1-Year Low: XX on 2025-02-13 Engagements by network (24h): Reddit: XXX TikTok: XXXXXX X: XXXXXX YouTube: XXXXX ### Mentions: XX (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/posts_active.tsv) Current Value: XX Daily Average: XX X Week: XXX -XX% X Month: XXX +71% X Months: XXXXX +111% X Year: XXXXX +155% 1-Year High: XXX on 2025-06-28 1-Year Low: X on 2025-01-27 Mentions by network (24h): Reddit: XX TikTok: XX X: XXX YouTube: XX ### Creators: XX (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning CG Oncology, Inc. Common stock (CGON) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX X Week: XXX -XX% X Month: XXX +41% X Months: XXXXX +211% X Year: XXXXX +156% 1-Year High: XXX on 2025-06-28 1-Year Low: X on 2025-01-27 The most influential creators that mention CG Oncology, Inc. Common stock in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@marco125](/creator/youtube/marco125) | X | XXXXXX | X | XXXXX | | [@BiopharmIQ](/creator/twitter/BiopharmIQ) | X | XXXXXX | X | XXX | | [@RedChip](/creator/twitter/RedChip) | X | XXXXX | X | XXX | | [@RipInteresting7326](/creator/reddit/RipInteresting7326) | X | | X | XXX | | [@seedytx19](/creator/twitter/seedytx19) | X | XXXXX | X | XXX | | [@Biobeats99](/creator/twitter/Biobeats99) | X | XXX | X | XX | | [@TKkamen](/creator/twitter/TKkamen) | X | XX | X | XX | | [@OzmosiHealth](/creator/twitter/OzmosiHealth) | X | XXXXX | X | XX | | [@James7Dolph](/creator/twitter/James7Dolph) | X | XX | X | X | | [@TrendingShared](/creator/twitter/TrendingShared) | XX | XX | X | X | [View More](/list/creators/$cgon/100) ### Sentiment: XX%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/sentiment.tsv) Current Value: XX% Daily Average: XX% X Week: XX% -X% X Month: XXX% +11% X Months: XXX% no change X Year: XXX% +26% 1-Year High: XXX% on 2025-01-25 1-Year Low: X% on 2025-03-03 Most Supportive Themes: - Positive Clinical Trial Results: (70%) CG Oncology's recent positive clinical trial data for its bladder cancer therapy is a significant driver of investor confidence and positive sentiment. - Increased Social and Trading Activity: (22%) A notable surge in trading volume and social media engagement indicates growing interest and attention towards CGON. - Guggenheim Buy Rating: (8%) Guggenheim's initiation of coverage with a 'Buy' rating and a $XX price target provides a strong endorsement and potential upside for the stock. Most Critical Themes: - Analyst Downgrade: (8%) An unspecified analyst downgrade is creating negative pressure on the stock, despite the otherwise positive news. ### Social Dominance: XXXX%  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/social_dominance.tsv) Current Value: XXXX% Daily Average: XXXXXXX% X Week: XXXXX% +0.006% X Month: XXXXX% +0.018% X Months: XXXXX% +0.017% X Year: XXXXX% +0.014% 1-Year High: XXXXX% on 2025-04-28 1-Year Low: XXXXXX% on 2025-02-13 ### Market Dominance: XXXXXXX%  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/market_dominance.tsv) Current Value: XXXXXXX% Daily Average: X% 1-Year High: XXXX% on 2025-03-31 1-Year Low: XXXXXXX% on 2025-04-08 ### Market Cap: $XXXXXXXXXXXXX  [Market Cap 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/market_cap.tsv) Current Value: $XXXXXXXXXXXXX Daily Average: $XXXXXXXXXXXXX X Week: $XXXXXXXXXXXXX +$0.89% X Month: $XXXXXXXXXXXXX +$5.20% X Months: $XXXXXXXXXXXXX +$67% X Year: $XXXXXXXXXXXXX +$33% 1-Year High: $XXXXXXXXXXXXX on 2025-11-25 1-Year Low: $XXXXXXXXXXXXX on 2025-04-08 ### Top CG Oncology, Inc. Common stock Social Posts Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "CG On Top 🤯#automobile#splendormodified#cg125#hondacg125#hondamotorcycle#unfrezzmyaccount#shorts" [YouTube Link](https://youtube.com/watch?v=ERW2yTzlPVY) [@marco125](/creator/youtube/marco125) 2025-12-09T05:13Z 57.4K followers, 11.7K engagements "Entered $CGON Potential play is the break-out of this VCP. Should not violate previous low. Hopefully it tightens up here. Previous buy order did not go through unfortunately" [X Link](https://x.com/CBN_trades/status/1998115454699606418) [@CBN_trades](/creator/x/CBN_trades) 2025-12-08T19:40Z XX followers, XX engagements "Jefferies Structure Therapeutics' robust Phase X data for its oral GLP-1 receptor agonist solidifies its profile as a Phase 3-ready asset in the competitive obesity market. Full report in Bio $GPCR $LLY $NVO $AMGN $ALT $VKTX $CORT $BIIB $MNKD $KYMR $RXRX $CGON $DYN $AXSM" [X Link](https://x.com/Biobeats99/status/1998084868396531816) [@Biobeats99](/creator/x/Biobeats99) 2025-12-08T17:38Z XXX followers, XXX engagements "Super bullish on this one $VERA $MIRM $IOVA $ABS $PRDS $RAPT $ODT $CTMX $PTPI $FREQ $PMVP $BPMC $UBX $GRTS $FRLN $ELDN $QURE $IDRA $CGON $NKTR $RIGL $AUTL $IMPL $KALV $EIGR $ORMP $RXDX $GRCL $ENOB $VTYX $ATHA $CARA $NRIX $PBYI $IMRA $SPRO $PNT $ENLV $GBIO" [X Link](https://x.com/BuyTheUgly/status/1998059426540892571) [@BuyTheUgly](/creator/x/BuyTheUgly) 2025-12-08T15:57Z XX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
CG Oncology presents positive Phase X bladder cancer data, driving high sentiment and social engagement, despite a minor analyst downgrade.
CG Oncology, Inc. is a biopharmaceutical company focused on developing treatments for bladder cancer.
CG Oncology, Inc. Common stock uses the ticker $CGON for trading. Listed in the Stocks category.
Price 24-Hour Time-Series Raw Data
The stock price is likely increasing due to positive clinical trial data, high sentiment, and a surge in social engagement, supported by a Guggenheim buy rating and target price of $90, despite a recent minor price drop.
24-Hour: -XXXX% 7-Day: -XXXX% 30-Day: XXXX%
1-Year High: $XXXXX on 2025-11-25
1-Year Low: $XXXXX on 2025-04-08
AltRank 24-Hour Time-Series Raw Data
CG Oncology, Inc. Common stock (CGON) is currently AltRank #662 based on combined combined social and market metrics
Daily Average: XXXXX
X Week: XXX -XX
X Month: XXX -XXX
X Months: XXX +84
X Year: XXX -XXX
1-Year High: XXXXX on 2025-08-11
1-Year Low: XX on 2025-04-28
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX -X
X Months: XX -X
X Year: XX -XX
1-Year High: XX on 2025-03-04
1-Year Low: X on 2025-07-31
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXX
X Week: XXXXXX +144%
X Month: XXXXXXX +215%
X Months: XXXXXXXXX +51%
X Year: XXXXXXXXX +39%
1-Year High: XXXXXXX on 2025-04-28
1-Year Low: XX on 2025-02-13
Engagements by network (24h): Reddit: XXX TikTok: XXXXXX X: XXXXXX YouTube: XXXXX
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX -XX%
X Month: XXX +71%
X Months: XXXXX +111%
X Year: XXXXX +155%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-01-27
Mentions by network (24h): Reddit: XX TikTok: XX X: XXX YouTube: XX
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning CG Oncology, Inc. Common stock (CGON) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XXX -XX%
X Month: XXX +41%
X Months: XXXXX +211%
X Year: XXXXX +156%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-01-27
The most influential creators that mention CG Oncology, Inc. Common stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @marco125 | X | XXXXXX | X | XXXXX |
| @BiopharmIQ | X | XXXXXX | X | XXX |
| @RedChip | X | XXXXX | X | XXX |
| @RipInteresting7326 | X | X | XXX | |
| @seedytx19 | X | XXXXX | X | XXX |
| @Biobeats99 | X | XXX | X | XX |
| @TKkamen | X | XX | X | XX |
| @OzmosiHealth | X | XXXXX | X | XX |
| @James7Dolph | X | XX | X | X |
| @TrendingShared | XX | XX | X | X |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XXX% +11%
X Months: XXX% no change
X Year: XXX% +26%
1-Year High: XXX% on 2025-01-25
1-Year Low: X% on 2025-03-03
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXX%
Daily Average: XXXXXXX%
X Week: XXXXX% +0.006%
X Month: XXXXX% +0.018%
X Months: XXXXX% +0.017%
X Year: XXXXX% +0.014%
1-Year High: XXXXX% on 2025-04-28
1-Year Low: XXXXXX% on 2025-02-13
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-04-08
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$0.89%
X Month: $XXXXXXXXXXXXX +$5.20%
X Months: $XXXXXXXXXXXXX +$67%
X Year: $XXXXXXXXXXXXX +$33%
1-Year High: $XXXXXXXXXXXXX on 2025-11-25
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"CG On Top 🤯#automobile#splendormodified#cg125#hondacg125#hondamotorcycle#unfrezzmyaccount#shorts"
YouTube Link @marco125 2025-12-09T05:13Z 57.4K followers, 11.7K engagements
"Entered $CGON Potential play is the break-out of this VCP. Should not violate previous low. Hopefully it tightens up here. Previous buy order did not go through unfortunately"
X Link @CBN_trades 2025-12-08T19:40Z XX followers, XX engagements
"Jefferies Structure Therapeutics' robust Phase X data for its oral GLP-1 receptor agonist solidifies its profile as a Phase 3-ready asset in the competitive obesity market. Full report in Bio $GPCR $LLY $NVO $AMGN $ALT $VKTX $CORT $BIIB $MNKD $KYMR $RXRX $CGON $DYN $AXSM"
X Link @Biobeats99 2025-12-08T17:38Z XXX followers, XXX engagements
"Super bullish on this one $VERA $MIRM $IOVA $ABS $PRDS $RAPT $ODT $CTMX $PTPI $FREQ $PMVP $BPMC $UBX $GRTS $FRLN $ELDN $QURE $IDRA $CGON $NKTR $RIGL $AUTL $IMPL $KALV $EIGR $ORMP $RXDX $GRCL $ENOB $VTYX $ATHA $CARA $NRIX $PBYI $IMRA $SPRO $PNT $ENLV $GBIO"
X Link @BuyTheUgly 2025-12-08T15:57Z XX followers, XXX engagements
/topic/$cgon